The progress in epidemiological, diagnosis and treatment of primary hemifacial spasm
Guangfa Xiang,Minghong Sui,Naifu Jiang,Rui Luo,Jianwei Xia,Xinling Wei,Yifeng Lin,Xingyu Li,Zixiang Cai,Junxia Lin,Shipei Li,Wanyi Chen,Yang Zhao,Lin Yang
DOI: https://doi.org/10.1016/j.heliyon.2024.e38600
IF: 3.776
2024-09-30
Heliyon
Abstract:Hemifacial Spasm is a neurological disorder characterized by persistent and rhythmic spasms of the facial muscles, significantly affecting the patient's quality of life. This condition can be classified into primary and secondary types; this article focuses on the characteristics of primary hemifacial spasm. Epidemiological studies indicate that the condition is more common in women, older adults, and individuals with posterior fossa stenosis or uneven blood flow dynamics, and is associated with gene expression related to demyelinating lesions. In terms of diagnosis, magnetic resonance imaging can show the location of arterial or venous compression on the facial nerve on a macroscopic level and reveal white matter lesions on a microscopic level. Additionally, optimized electrophysiological techniques can determine the type of neural excitation disorder from both central and peripheral perspectives, thereby improving detection rates. There are numerous treatment options available. Although early oral medications may have limited effectiveness, botulinum toxin injections can provide temporary relief. Future considerations include balancing injection costs with long-term efficacy. Microvascular decompression remains the preferred treatment approach and can be further optimized with endoscopic techniques. For refractory cases, alternative therapies such as facial nerve massage, radiofrequency techniques, rhizotomy, or acupuncture may be considered.